Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Dec;140(6):1708-1710.e1.
doi: 10.1016/j.jaci.2017.04.052. Epub 2017 Jun 15.

Relationship between EASI and SCORAD severity assessments for atopic dermatitis

Rishi Chopra  1 , Paras P Vakharia  1 , Ryan Sacotte  1 , Neha Patel  1 , Supriya Immaneni  1 , Takeshia White  1 , Robert Kantor  1 , Derek Y Hsu  1 , Jonathan I Silverberg  2
Affiliations
Observational Study

Relationship between EASI and SCORAD severity assessments for atopic dermatitis

Rishi Chopra et al. J Allergy Clin Immunol. 2017 Dec.

Abstract

The present study shows a complex relationship between EASI and SCORAD. The results provide support for inclusion of objective-SCORAD and/or SCORAD in addition to EASI in clinical trials.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None

Funding/Sponsor was involved? No

Design and conduct of the study: Yes__ No_X_

Collection, management, analysis and interpretation of data: Yes__ No_X_

Preparation, review, or approval of the manuscript: Yes__ No_X_

Decision to submit the manuscript for publication: Yes__ No_X_

Figures

Figure 1
Figure 1. Relationship between EASI, oSCORAD, SCORAD and POEM
Scatterplots and penalized-splines are plotted for (A) SCORAD vs. EASI, (B) oSCORAD vs. EASI, (C) POEM vs. EASI, (D) POEM vs. SCORAD, and (E) POEM vs. oSCORAD. Mean BSA was 23.8%±27.6%, EASI was 8.7±11.3, oSCORAD was 22.7±15.0, SCORAD was 31.0±18.2, and POEM was 10.7±7.0.
See this image and copyright information in PMC

References

    1. Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S, et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134:800–7. - PubMed
    1. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92:44–7.
    1. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10:11–8. - PubMed
    1. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195:10–9. - PubMed
    1. Charman CR, Venn AJ, Williams H. Measuring atopic eczema severity visually: which variables are most important to patients? Arch Dermatol. 2005;141:1146–51. discussion 51. - PubMed

Publication types